Market Research Logo

Global Bio CMO Market: Size, Trends & Forecasts (2018-2022)

Global Bio CMO Market: Size, Trends & Forecasts (2018-2022)

Scope of the Report

The report entitled “Global Bio CMO Market: Size, Trends & Forecasts (2018-2022)”, provides analysis of the global bio CMO market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The report also provides the analysis of the global biologics market by value, by top selling products, etc.

Growth of the overall global bio CMO market has been forecasted for the years 2017-2022, taking into consideration the previous growth pattern, the growth drivers and the current and future trends.

Lonza Group, Boehringer Ingelheim, Samsung Biologics and Wuxi Biologics are key companies in the global bio CMO market. The company profiling of these companies has been done in the report, which includes business overview, financial overview and respective business strategies of the companies.

Company Coverage

Lonza Group
Boehringer Ingelheim
Samsung Biologics
Wuxi Biologics

Executive Summary

Pharmaceutical industry comprise of discovering, developing, producing and marketing of drugs for medical use. World’s largest pharmaceutical firms are located in the North America, Europe and Japan. On the basis of technological platform, pharmaceutical drugs can be divided into small molecule or conventional drugs and large molecule or biologic drugs.

Biologics are made through biological processes and are generally injected. Biologics comprises of vaccines, blood or blood components, somatic cells, gene therapy, etc. Biologics are categorized into first-or second generation, depending on development period and cell line. Biosimilars are the biological that are similar, but not identical to the original product.

CMO or Contract Manufacturing Organization is a third party, which the pharmaceutical firms approach for the manufacturing of components of its product or whole of its product. Bio CMOs are typically used to provide secondary manufacturing coverage for the branded pharmaceutical industry. On the basis of production technology, bio CMOs can be divided into mammalian cell system and microbial system.

The global bio CMO market is expected to increase at a significant growth rate during the forecasted period (2017-2022). The global bio CMO market is supported by various growth drivers, such as increase in pharmaceutical industry, growth in use of biosimilars, potential biologics blockbusters, introduction of targeted therapins, grater outsourcing demand from global pharmas, etc. Yet, the market faces certain challenges, such as risk associated with CMOs, presence of in-house manufacturing facilities of big pharma companies, productivity issues with mammalian cell system, etc.


1. Executive Summary
2. Introduction
2.1 Pharmaceutical Industry Overview
Table 1: History of Pharmaceutical Industry
2.1.1 Segments of Pharmaceutical Industry (Drugs)
Table 2: Pharmaceutical Industry Segments
2.2 Biotechnology/Biologics Overview
Table 3: Chemical Drugs v/s 1st Generation Biologics v/s 2nd Generation Biologics
2.3 Biosimilar Overview
Table 4: US Approved Biosimilars
2.4 Biologics/ Biosimilar Manufacturing
2.5 Bio CMO Overview
2.5.1 Comparison: In-House Vs CMO Production
Table 5: Comparison: In-House Vs CMO Production
3. Global Market Analysis
3.1 Global Biologics Market: An Analysis
3.1.1 Global Biologics Market by Value
Table 6: Global Biologics Market by Value; 2016-2022E (US$ Billion)
3.1.2 Global Biologics Market by Top Selling Drugs
Table 7: Top Selling Biologics Drugs; 2016
3.1.3 Global Biologics Market by Product in Development
Table 8: Global Biologics Market by Products in Development; 2015-2016
3.1.4 Global Biologics Manufacturing Market by Value
Table 9: Global Biologics Manufacturing Market by Value; 2012-2016 (US$ Billion)
Table 10: Global Biologics Manufacturing Market by Value; 2017-2022E
(US$ Billion)
3.2 Global Bio CMO Market: An Analysis
3.2.1 Global Bio CMO Market by Penetration Rate
Table 11: Global Bio CMO Market by Penetration Rate; 2012-2016 (%)
Table 12: Global Bio CMO Market by Penetration Rate; 2017-2022E (%)
3.2.2 Global Bio CMO Market by Value
Table 13: Global Bio CMO Market by Value; 2012-2016 (US$ Billion)
Table 14: Global Bio CMO Market by Value; 2017-2022 (US$ Billion)
3.2.3 Global Bio CMO Market by Capacity
Table 15: Global Bio CMO Market by Capacity; 2014-2016 (KL)
Table 16: Global Bio CMO Market by Capacity; 2017-2022E (KL)
3.2.4 Global Bio CMO Market by Segments
Table 17: Global Bio CMO Market by Segments; 2015
3.2.5 Global Bio CMO Market by Manufacturing Processes
Table 18: Global Bio CMO Market by Manufacturing Processes; 2016
3.3 Global Bio CMO Market Segment Analysis
3.3.1 Global Bio CMO Downstream Process Market by Value
Table 19: Global Bio CMO Downstream Process Market by Value; 2012-2016
(US$ Billion)
Table 20: Global Bio CMO Downstream Process Market by Value; 2017-2022E
(US$ Billion)
3.3.2 Global Bio CMO Upstream Process Market by Value
Table 21: Global Bio CMO Upstream Process Market by Value; 2012-2016
(US$ Billion)
Table 22: Global Bio CMO Upstream Process Market by Value; 2017-2022E
(US$ Billion)
3.3.3 Global Bio CMO Fill and Finish Process Market by Value
Table 23: Global Bio CMO Fill and Finish Process Market by Value; 2012-2016
(US$ Billion)
Table 24: Global Bio CMO Fill and Finish Process Market by Value; 2017-2022E
(US$ Billion)
4. Competitive Landscape
4.1 Global Bio CMO Market by Players
Table 25: Global Bio CMO Market Revenue by Players; 2016
4.2 Global Bio CMO Players by Capacity
Table 26: Global Bio CMO Players by Capacity; 1H16 (KL)
5. Company Profiles
5.1 Lonza Group
5.1.1 Business Overview
5.1.2 Financial Overview
Table 27: Lonza Group Sales; 2012-2016 (US$ Billion)
Table 28: Lonza Group Sales by Region; 2016
Table 29: Lonza Group Sales by Segments; 2016
5.1.3 Business Strategy
5.2 Boehringer Ingelheim
5.2.1 Business Overview
5.2.2 Financial Overview
Table 30: Boehringer Ingelheim Sales; 2012-2016 (US$ Billion)
Table 31: Boehringer Ingelheim Sales by Segments; 2016
Table 32: Boehringer Ingelheim Sales by Region; 2016
5.2.3 Business Strategy
5.3 Samsung Electronics (Samsung Biologics)
5.3.1 Business Overview
Table 33: Samsung Electronics Segments Overview
Table 34: Samsung Electronics Ownership Structure
5.3.2 Financial Overview
Table 35: Samsung Electronics and Biologics Revenue; 2012-2016 (US$ Billion)
Table 36: Samsung Electronics Revenue by Segments; 2016
5.3.3 Business Strategy
5.4 Wuxi Biologics
5.4.1 Business Overview
5.4.2 Financial Overview
Table 37: Wuxi Biologics Revenue; 2014-2016 (US$ Million)
Table 38: Wuxi Biologics Revenue by Services; 2016
Table 39: Wuxi Biologics Revenue by Fee Model; 2016
5.4.3 Business Strategy

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report